Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant-Reference-Cited by-同舟云学术

Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant

Published:2010-06 Issue:6 Volume:51 Page:995-1006
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Godley Lucy A.,Njiaju Uchenna O.,Green Margaret,Weiner Howard,Lin Shang,Odenike Olatoyosi,Rich Elizabeth S.,Artz Andrew,Van Besien Koen,Daugherty Christopher K.,Zhang Yanming,Le Beau Michelle M.,Stock Wendy,Larson Richard A

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428191003763468

Reference30 articles.

1. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

2. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

3. Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: Report from an International Workshop†

4. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloid leukemia during osimertinib treatment in a non-small cell lung cancer patient: A case report;Heliyon;2024-09

2. Adult rhabdomyosarcoma combined with acute myeloid leukemia: A case report;World Journal of Clinical Cases;2024-01-26

3. Clinical outcomes of therapy-related acute myeloid leukemia: over 20 years long single center retrospective analysis;Polish Archives of Internal Medicine;2022-09-27

4. Genetic Pathway in the Pathogenesis of Therapy-Related Myeloid Neoplasms: A Literature Review;Oncology and Therapy;2020-03-16

5. A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia;Blood Advances;2020-02-13